Diabetes mellitus after renal transplantation - As deleterious as non-transplant-associated diabetes?
Diabetes mellitus after renal transplantation - As deleterious as non-transplant-associated diabetes?
复制标题
DOI:
10.1097/00007890-199802150-00014
复制
发表时间:
1998-02-15
期刊:
影响因子:
6.2
通讯作者:
Friedman, EA
中科院分区:
文献类型:
--
作者:
Miles, AMV;Sumrani, N;Friedman, EA
Background. Despite use of lower doses of corticosteroid hormones after renal allotransplantation in the era of cyclosporine and tacrolimus, posttransplant diabetes mellitus remains a common clinical problem,Methods, We prospectively investigated the effect of posttransplant diabetes on long-term (mean follow-up, 9.3+/-1.5 years) graft and patient survival in the 11.8% of our renal transplant population (n=40) who developed diabetes after kidney transplantation, and we compared outcome in 38 randomly chosen nondiabetic control patients who had received transplants concurrently,Results, Twelve-year graft survival in diabetic patients was 48%, compared with 70% in control patients (P=0.04), and Cox's regression analysis revealed diabetes to be a significant predictor of graft loss (P=0.04, relative risk=3.72) independent of age, sex, and race, Renal function at 5 years as assessed by serum creatinine level was inferior in diabetic patients compared to control patients (2.9+/-2.6 vs, 2.0+/-0.07 mg/dl, P=0.05), Two diabetic patient who experienced graft loss had a clinical course and histological features consistent with diabetic nephropathy; other diabetes-related morbidity in patients with posttransplant diabetes included ketoacidosis, hyperosmolar coma or precoma, and sensorimotor peripheral neuropathy, Patient survival at 12 years was similar in diabetic and control patients (71% vs, 74%).Conclusions, Posttransplant diabetes mellitus is associated with impaired long-term renal allograft survival and function, complications similar to those in non-transplant-associated diabetes may occur in posttransplant diabetes, and, hence, as in non-transplant-associated diabetes, tight glycemic control may also be warranted in patients with posttransplant diabetes.